For individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) treatment is associated with a reduced risk for kidney ...
A new clinical decision support tool for primary care providers (PCPs) led to a modest improvement in reinitiation of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers ...
Please provide your email address to receive an email when new articles are posted on . Patients with advanced chronic kidney disease may benefit from use of angiotensin-converting enzyme inhibitors ...
In a recent study published in the Scientific Reports Journal, a group of researchers compared the effects of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) ...
Association of asynchronous, time-flexible digital multidisciplinary care with overall survival in advanced biliary tract cancer treated with immune checkpoint inhibitors. Envafolimab (KN035) plus ...
Angioedema is a well-known side effect of treatment with an angiotensin-converting enzyme (ACE) inhibitor and one that we have been willing to accept in view of the incidence of the problem and the ...
No significant interactions were seen between ACEi or ARB treatment and age, estimated glomerular filtration rate, albuminuria, or diabetes. HealthDay News — For individuals with advanced chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results